Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension

Clinical trial NCT06604897 · COMPLETED

Trial details

NCT number: NCT06604897
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Essential Hypertension

Start date: 2023-01-31
Primary completion: 2025-10-31
Enrollment: 1405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.